This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: National Research Council of Canada. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Rénald Gilbert: Innovator in Antibody Research
Introduction
Rénald Gilbert is a prominent inventor based in Montréal, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of innovative antibodies that can cross the blood-brain barrier. With a total of 3 patents to his name, Gilbert's work is paving the way for new therapeutic approaches.
Latest Patents
One of Gilbert's latest patents focuses on insulin-like growth factor 1 receptor-specific antibodies and their uses. The blood-brain barrier (BBB) is a critical structure that prevents the transport of molecules larger than 500 Daltons from the blood to the brain. Gilbert's research identifies an insulin-like growth factor 1 receptor (IGF1R)-binding antibody or fragment that can transmigrate the BBB through receptor-mediated transcytosis (RMT). This antibody is designed to deliver cargo molecules across the BBB, which may include therapeutic or detectable agents. The antibody is a camelid VHH, developed by immunizing a llama with a 933-amino acid IGF1R polypeptide. Additionally, humanized forms of the camelid VHH have also been generated.
Career Highlights
Rénald Gilbert is affiliated with the National Research Council of Canada, where he continues to advance his research in antibody development. His innovative work has garnered attention in the scientific community and has the potential to impact various therapeutic applications.
Collaborations
Gilbert collaborates with esteemed colleagues, including Danica Stanimirovic and Arsalan S Haqqani, who contribute to the research and development of his projects.
Conclusion
Rénald Gilbert's contributions to antibody research are noteworthy and demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of interdisciplinary efforts in tackling complex biomedical challenges.